Directly observed treatment for tuberculosis

BMJ

Volumn 313, Issue 7048, 1996, Pages 45-

  Sell, Louise ^a   Finch, Emily ^a   Farrell, Michael ^a   Sheridan, Janie ^a   Strang, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; TUBERCULOSTATIC AGENT;

HUMAN; LETTER; PATIENT COMPLIANCE; PHARMACY; SUBSTANCE ABUSE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COMMUNITY PHARMACY SERVICES; HUMANS; METHADONE; PATIENT COMPLIANCE; SUBSTANCE ABUSE, INTRAVENOUS; TUBERCULOSIS;

EID: 0030003367     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7048.45a     Document Type: Letter

References (4)

1. Morse MD. Directly observed therapy for tuberculosis. BMJ 1996; 312: 719–20. (23 March.)
2. Advisory Council on the Misuse of Drugs. AIDS and drug misuse update. London: HMSO, 1993.
3. Ball JC, Ross R. The effectiveness of methadone maintenance treatment: patients, programs, services and outcome. New York: Springer-Verlag, 1991.
4. Stewart GH, Nelson N. Tuberculosis in the United Kingdom. BMJ 1996; 312: 775–6. (23 March.)